Get the Stockscreener App
484.16
0.12%
-0.39
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $484.16, with a volume of 602.65K.
It is down -0.12% in the last 24 hours and up +3.73% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$484.55
Open:
$482.08
24h Volume:
602.65K
Relative Volume:
0.24
Market Cap:
$182.82B
Revenue:
$43.21B
Net Income/Loss:
$6.58B
P/E Ratio:
28.00
EPS:
17.29
Net Cash Flow:
$6.17B
1W Performance:
-1.17%
1M Performance:
+3.73%
6M Performance:
-6.31%
1Y Performance:
-20.90%
1-Day Range:
$471.61
$484.74
1-Week Range:
$471.61
$494.28
52-Week Range:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
484.15 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
196.17 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.37 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
126.85 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.79 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
What’s the analyst consensus on Thermo Fisher Scientific Inc.Inflation Watch & High Conviction Buy Zone Alerts - khodrobank.com
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Benzinga
Thermo Fisher completes purchase of Sanofi site in New Jersey - WFMZ.com
Is Thermo Fisher Scientific Inc.’s growth already priced inVolume Spike & Technical Buy Zone Confirmations - khodrobank.com
Here’s Why Thermo Fisher Scientific (TMO) Traded Lower in Q2 - Yahoo Finance
Biobanking Services Market Expansion Led by Key Players: Thermo - openPR.com
Earnings visualization tools for Thermo Fisher Scientific Inc.July 2025 Recap & Expert Curated Trade Ideas - Newser
RBC Trims Price Target on Thermo Fisher Scientific to $561 From $572, Keeps Outperform Rating - MarketScreener
Can trapped investors hope for a rebound in Thermo Fisher Scientific Inc.2025 Top Gainers & Reliable Price Breakout Alerts - Newser
Thermo Fisher acquires Solventum’s filtration unit for $4B - Modern Healthcare
Does Thermo Fisher Scientific Inc. show high probability of reboundJuly 2025 Drop Watch & Consistent Growth Stock Picks - Newser
Flow Cytometry Market Insights, Growth Outlook and - GlobeNewswire
Should you hold or exit Thermo Fisher Scientific Inc. now2025 Stock Rankings & Long-Term Safe Investment Plans - Newser
Thermo Fisher Scientific Inc. stock daily chart insightsPortfolio Performance Summary & Short-Term Swing Trade Alerts - Newser
Thermo Fisher Scientific Inc. stock retracement – recovery analysisQuarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
What data driven models say about Thermo Fisher Scientific Inc.’s futureJuly 2025 Review & Real-Time Chart Breakout Alerts - Newser
Thermo Fisher Scientific concludes acquisition of Sanofi New Jersey site - Medical Dialogues
How liquid is Thermo Fisher Scientific Inc. stockJuly 2025 Reactions & Consistent Growth Equity Picks - khodrobank.com
Thermo Fisher Plummets 1.05% on $630M Trading Volume Ranked 165th as Acquisition Expands U.S. Pharma Manufacturing Footprint - AInvest
Why Thermo Fisher Scientific Stock Tumbled Today - The Motley Fool
Thermo Fisher (TMO) VP Holmes sells $189k in stock - Investing.com
Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site - citybiz
Thermo Fisher Scientific Acquires Solventum’s Purification and Filtration Business For $4 Billion - citybiz
Published on: 2025-09-02 13:48:47 - Newser
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific - MarketScreener
Thermo Fisher Scientific Inc. completed the acquisition of Purification Business of Solventum Corporation for approximately $4 billion. - MarketScreener
Historical volatility pattern of Thermo Fisher Scientific Inc. visualizedWeekly Trade Report & Weekly Breakout Watchlists - Newser
Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business - PharmiWeb.com
Thermo Fisher Completes $4 Billion Solventum Acquisition - TipRanks
Thermo Fisher Scientific Acquires NJ Site from Sanofi - Contract Pharma
Solventum completes $4.1B sale of Purification & Filtration business to Thermo Fisher - MassDevice
Solventum Closes Sale of Purification, Filtration Business to Thermo Fisher - MarketScreener
Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield Facility in New Jersey - MarketScreener
Thermo Fisher’s Strategic Acquisition of Sanofi’s Ridgefield Site and Its Impact on Biopharma Manufacturing Growth - AInvest
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. - MarketScreener
$4 Billion Deal: Solventum Divests P&F Business to Thermo Fisher, Plans Major Debt Reduction - Stock Titan
Is Thermo Fisher Scientific Inc. stock undervalued right nowGlobal Markets & Trade Opportunity Analysis - خودرو بانک
Thermo Fisher Scientific's Valuation: Assessing Growth Potential After New Facility and Nalgene Product Launches - Yahoo Finance
Can swing trading help recover from Thermo Fisher Scientific Inc. lossesWeekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Volume spikes in Thermo Fisher Scientific Inc. stock – what they mean2025 Bull vs Bear & Verified Entry Point Signals - Newser
Can Thermo Fisher Scientific Inc. expand into new marketsMarket Activity Report & Fast Entry Momentum Alerts - خودرو بانک
Is Thermo Fisher Scientific Inc. impacted by rising rates2025 Support & Resistance & Risk Controlled Stock Pick Alerts - خودرو بانک
Thermo Fisher Expands US Base With New Mebane Facility - Healthcare Digital
Price Over Earnings Overview: Thermo Fisher Scientific - Benzinga
Combining machine learning predictions for Thermo Fisher Scientific Inc.Quarterly Portfolio Summary & Target Return Focused Picks - Newser
PFAS Testing Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Danaher Dominate with Advanced Analytical Solutions, Strategic Acquisitions, and Regulatory-Driven Innovations - Yahoo Finance
Does Thermo Fisher Scientific Inc. meet Warren Buffett’s criteria2025 Price Targets & Community Consensus Trade Alerts - خودرو بانک
What’s next for Thermo Fisher Scientific Inc. stock priceM&A Rumor & High Accuracy Swing Trade Signals - Newser
Is this a good reentry point in Thermo Fisher Scientific Inc.Quarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Comparing Thermo Fisher Scientific Inc. in custom built stock radars2025 Price Targets & High Accuracy Trade Alerts - Newser
Did Thermo Fisher's (TMO) New Carbon Neutral Plant Just Reinforce Its U.S. Supply Chain Advantage? - simplywall.st
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.63%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):